Jun Qin
15Patents
4h-index
68Co-inventors
59Inventor score
Filing activity: May 11, 2006 → Nov 1, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7763623B2 | Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia | Human Necessities | 8 | Active |
| US8450343B2 | Gamma secretase modulators | Chemistry; Metallurgy | 7 | Active |
| US8927559B2 | Quinazolinone-type compounds as CRTH2 antagonists | Chemistry; Metallurgy | 4 | Active |
| US8518975B2 | Gamma secretase modulators | Chemistry; Metallurgy | 4 | Active |
| US7723342B2 | Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia | Chemistry; Metallurgy | 3 | Expired |
| US7737155B2 | Nitrogen-containing heterocyclic compounds and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US8673900B2 | Gamma secretase modulators | Chemistry; Metallurgy | 2 | Active |
| US7750015B2 | Nitrogen-containing heterocyclic compounds and methods of use thereof | Human Necessities | 2 | Active |
| US9469615B2 | Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulators | Chemistry; Metallurgy | 1 | Active |
| US8357682B2 | Gamma secretase modulators | Chemistry; Metallurgy | 1 | Active |
| US12116350B2 | Compounds for treating ILK-mediated diseases | Human Necessities | 0 | Active |
| US10385034B2 | Flavonoid IL-17A inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8846884B2 | Method for enrichment and isolation of endogenous transcription factor and complexes thereof and corresponding tandem arrays of concatenated transcription factor response elements | Chemistry; Metallurgy | 0 | Active |
| US11524945B2 | Compounds for treating ILK-mediated diseases | Human Necessities | 0 | Active |
| US8809318B2 | Gamma secretase modulators | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.